Genovate Biotechnology (Taiwan) Buy Hold or Sell Recommendation

4130 Stock  TWD 21.80  0.15  0.68%   
Assuming the 90 days trading horizon and your slightly conservative level of risk, our recommendation regarding Genovate Biotechnology Co is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Genovate Biotechnology Co given historical horizon and risk tolerance towards Genovate Biotechnology. When Macroaxis issues a 'buy' or 'sell' recommendation for Genovate Biotechnology Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Genovate Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Genovate and provide practical buy, sell, or hold advice based on investors' constraints. Genovate Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Genovate Biotechnology Buy or Sell Advice

The Genovate recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genovate Biotechnology Co. Macroaxis does not own or have any residual interests in Genovate Biotechnology Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genovate Biotechnology's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Genovate BiotechnologyBuy Genovate Biotechnology
Strong Sell

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Genovate Biotechnology Co has a Mean Deviation of 0.6356, Standard Deviation of 0.8989 and Variance of 0.808
Our trade recommendations module complements current analysts and expert consensus on Genovate Biotechnology Co. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Genovate Biotechnology Co is not overpriced, please check out all Genovate Biotechnology fundamentals, including its shares owned by insiders, price to book, and the relationship between the shares outstanding and shares owned by institutions .

Genovate Biotechnology Trading Alerts and Improvement Suggestions

Genovate Biotechnology generated a negative expected return over the last 90 days
Genovate Biotechnology generates negative cash flow from operations

Genovate Biotechnology Returns Distribution Density

The distribution of Genovate Biotechnology's historical returns is an attempt to chart the uncertainty of Genovate Biotechnology's future price movements. The chart of the probability distribution of Genovate Biotechnology daily returns describes the distribution of returns around its average expected value. We use Genovate Biotechnology Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genovate Biotechnology returns is essential to provide solid investment advice for Genovate Biotechnology.
Mean Return
-0.0084
Value At Risk
-1.54
Potential Upside
1.34
Standard Deviation
0.90
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genovate Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Genovate Biotechnology Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genovate Biotechnology or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genovate Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genovate stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.0077
β
Beta against Dow Jones-0.11
σ
Overall volatility
0.88
Ir
Information ratio -0.13

Genovate Biotechnology Volatility Alert

Genovate Biotechnology Co exhibits very low volatility with skewness of -0.81 and kurtosis of 1.94. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genovate Biotechnology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genovate Biotechnology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Genovate Biotechnology Fundamentals Vs Peers

Comparing Genovate Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genovate Biotechnology's direct or indirect competition across all of the common fundamentals between Genovate Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genovate Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genovate Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genovate Biotechnology by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Genovate Biotechnology to competition
FundamentalsGenovate BiotechnologyPeer Average
Return On Equity0.0022-0.31
Return On Asset0.0015-0.14
Profit Margin0.01 %(1.27) %
Operating Margin0.01 %(5.51) %
Current Valuation3.16 B16.62 B
Shares Outstanding109.38 M571.82 M
Shares Owned By Insiders3.95 %10.09 %
Shares Owned By Institutions26.96 %39.21 %
Price To Book2.62 X9.51 X
Price To Sales9.42 X11.42 X
Revenue434.25 M9.43 B
Gross Profit149.75 M27.38 B
EBITDA39.64 M3.9 B
Net Income372 K570.98 M
Book Value Per Share12.82 X1.93 K
Cash Flow From Operations(17.26 M)971.22 M
Earnings Per Share0.03 X3.12 X
Number Of Employees18118.84 K
Beta0.21-0.15
Market Capitalization3.3 B19.03 B
Total Asset1.52 B29.47 B
Annual Yield0.01 %
Net Asset1.52 B
Last Dividend Paid0.35

Genovate Biotechnology Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genovate . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Genovate Biotechnology Buy or Sell Advice

When is the right time to buy or sell Genovate Biotechnology Co? Buying financial instruments such as Genovate Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Genovate Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Crypto And Gold Thematic Idea Now

Crypto And Gold
Crypto And Gold Theme
Assets that cancel away each other volatility by providing diversification into gold investment combined with digital assets. The Crypto And Gold theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Crypto And Gold Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Genovate Stock Analysis

When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.